Ondansetron Dosing and Administration for Pediatric Patients

Weight-Based Dosing and Administration

The American Academy of Pediatrics recommends weight-based dosing for pediatric patients, with intramuscular/intravenous route dosing at 0.15 mg/kg per dose, and a maximum of 16 mg per dose, for moderate-to-severe presentations or when oral route fails, as supported by the Journal of Allergy and Clinical Immunology 1, 2

Special caution is warranted in children with underlying heart disease due to ondansetron's potential to prolong the QT interval, as noted by the Journal of Allergy and Clinical Immunology 1
Ondansetron should only be used in children ≥6 months of age for acute gastroenteritis management, according to the Journal of Allergy and Clinical Immunology 1, 2
It is crucial to screen for cardiac history, including congenital heart disease or arrhythmias, before ondansetron administration, as recommended by the Journal of Allergy and Clinical Immunology 1

The Infectious Diseases Society of America (IDSA) recommends ondansetron as an antiemetic to facilitate oral rehydration in children >4 years of age with acute gastroenteritis associated with vomiting 3, 4
The American Academy of Pediatrics recommends weight-based dosing of ondansetron for pediatric patients with persistent vomiting due to its efficacy and favorable side effect profile 5

Special caution might be warranted in children with heart disease due to the potential of ondansetron to prolong the QT interval 6

Antiemetic treatment should not replace appropriate fluid and electrolyte therapy, which remains the mainstay of treatment for gastroenteritis 3, 4
Ondansetron should be used after ensuring adequate hydration or alongside rehydration efforts 3